>
 
                    
                    
                    
                    
                    44 Special vs. 357 Magnum: Which Cartridge Is Right for You?
 Both Canadian and U.S. RVers are reporting harassment because of political tensions
Both Canadian and U.S. RVers are reporting harassment because of political tensions
 TEENS Turn a BARREN Paddock Into a FARM That Feeds Their Community!
TEENS Turn a BARREN Paddock Into a FARM That Feeds Their Community!
 Putting a Price on Life: From 9/11 to the BP Oil Spill and Boston Marathon
Putting a Price on Life: From 9/11 to the BP Oil Spill and Boston Marathon
 Graphene Dream Becomes a Reality as Miracle Material Enters Production for Better Chips, Batteries
Graphene Dream Becomes a Reality as Miracle Material Enters Production for Better Chips, Batteries
 Virtual Fencing May Allow Thousands More Cattle to Be Ranched on Land Rather Than in Barns
Virtual Fencing May Allow Thousands More Cattle to Be Ranched on Land Rather Than in Barns
 Prominent Personalities Sign Letter Seeking Ban On 'Development Of Superintelligence'
Prominent Personalities Sign Letter Seeking Ban On 'Development Of Superintelligence'
 Why 'Mirror Life' Is Causing Some Genetic Scientists To Freak Out
 Why 'Mirror Life' Is Causing Some Genetic Scientists To Freak Out
 Retina e-paper promises screens 'visually indistinguishable from reality'
Retina e-paper promises screens 'visually indistinguishable from reality'
 Scientists baffled as interstellar visitor appears to reverse thrust before vanishing behind the sun
Scientists baffled as interstellar visitor appears to reverse thrust before vanishing behind the sun
 Future of Satellite of Direct to Cellphone
Future of Satellite of Direct to Cellphone
 Amazon goes nuclear with new modular reactor plant
Amazon goes nuclear with new modular reactor plant
 China Is Making 800-Mile EV Batteries. Here's Why America Can't Have Them
China Is Making 800-Mile EV Batteries. Here's Why America Can't Have Them

Patients with an inherited disease that caused them to lose much of their sight early in childhood experienced a quick return of vision after they received gene therapy.
The new treatment addressed the genetic mutation that caused their vision's deterioration, letting them see 100 times better than before.
Some patients even experienced a 10,000-fold improvement in their vision after receiving the highest dose of the therapy, according to researchers from the University of Pennsylvania's School of Medicine.
"One patient reported for the first time being able to navigate at midnight outdoors only with the light of a bonfire."
A total of 15 people participated in the Phase 1/2 trial, including three pediatric patients. Each patient suffered from Leber congenital amaurosis (LCA1) as a result of mutations in the GUCY2D gene, which is essential to producing proteins critical for vision. The rare condition, which affects 100,000 people worldwide, causes significant amount of vision loss as early as infancy.
All subjects had severe vision loss with their best measure of vision being equal or worse than 20/80—meaning if a typically-sighted person could see an object clearly at 80 feet, these patients would have to move up to at least 20 feet to see it. Glasses provide limited benefit to these patients because they correct abnormalities in the optical focusing ability of the eye, and are unable to address medical causes of vision loss, such as genetic retinal diseases like LCA1.